Roche said the layoffs at its Madison, Wisconsin site will start Dec. 31 and continue through June 30, 2020.
At the AGBT conference this week, the DNA synthesis discussed the new capture products and its overall business.
The firm envisions applying its new PlexSet technology to the upper end of multiplex gene expression analysis as well as CRISPR validation applications.
The researchers also applied their database to impute alleles in the region linked to psoriasis.
Heat-Seq, scheduled to launch in the second quarter, uses empirically tested molecular inversion probes.
The partnership will pair Sophia's informatics infrastructure with IDT's panel to provide an NGS-based solution for routine clinical diagnostics.
The scientists believe they have created a more accurate way to detect mutations that often lead to hereditary colorectal cancer.
According to the researchers, the method provides an alternative to commercially available solutions at a lower cost per sample.
Agilent Technologies and Ambry Genetics have signed an agreement under which Ambry will use Agilent's SureSelect Target Enrichment System for exome sequencing services, the companies said last week.
By Julia Karow
The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.
A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.
The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."
In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.